Dudediligence.

Cronos Group Inc

CRONNASDAQ · Medicinal Chemicals & Botanical Products
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$34.3MSep ’24$30.3MDec ’24$32.3MMar ’25$33.5MJun ’25$36.3MSep ’25$44.5MDec ’25$45.2MMar ’26$53.0MJun ’26
Net income, by quarter
$8.3MSep ’24$43.7MDec ’24$6.1MMar ’25−$39.7MJun ’25$26.0MSep ’25−$1.8MDec ’25$13.8MMar ’26$32.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$64.6M$86.7M$87.2M$117.6M$146.6M
Gross profit−$17.6M$15.4M$11.9M$25.2M$62.8M
Operating income−$292.0M−$111.4M−$84.8M−$76.5M−$17.4M
Net income−$396.1M−$168.7M−$74.0M$41.1M−$9.4M
Operating cash flow−$153.6M−$88.9M−$42.8M$18.8M$25.9M
Free cash flow−$164.8M−$92.4M−$45.3M$6.4M$149,000
Cash$887.0M$764.6M$669.3M$858.8M$791.8M
Shares outstanding375.0M380.6M381.3M382.5M381.6M